| Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods. (NCT00346827) | Britannia Pharmaceuticals Ltd. | 2006-07-01 |
| Neuroimaging Studies of Depression in Parkinson's Disease (NCT00518258) | Lee Blonder | 2006-07-01 |
| Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease (NCT00736671) | University of Michigan | 2006-07-01 |
| Psychiatric and Cognitive Manifestations of Parkinson's Disease (NCT00360633) | NYU Langone Health | 2006-06-01 |
| Improve Speech Using an In-the-ear Device in Parkinson's Disease (NCT00488657) | Rush University Medical Center | 2006-06-01 |
| Efficiency of Physiotherapeutic Care in Parkinson's Disease (NCT00330694) | Radboud University Medical Center | 2006-05-01 |
| Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone (NCT00324896) | University of Medicine and Dentistry of New Jersey | 2006-05-01 |
| A Trial of MitoQ for the Treatment of People With Parkinson's Disease (NCT00329056) | Antipodean Pharmaceuticals, Inc. | 2006-05-01 |
| Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease (NCT00646204) | Baylor College of Medicine | 2006-04-01 |
| Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients (NCT00461942) | Xuanwu Hospital, Beijing | 2006-04-01 |
| Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease (NCT00737217) | University of Michigan | 2006-03-01 |
| Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease (NCT00393562) | US Department of Veterans Affairs | 2006-03-01 |
| Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease (NCT00307450) | Technische Universität Dresden | 2006-03-01 |
| Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD) (NCT00282152) | Vanderbilt University Medical Center | 2006-03-01 |
| Measures of Motor Impairment in Early Parkinson's Disease (NCT00291265) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-02-09 |
| The Therapeutics Effects of Yoga in Individuals With Parkinson's Disease (NCT00312559) | University of Kansas | 2006-02-01 |
| The Effect of Electrode Implantation for Deep Brain Stimulation (DBS) on Brain Function Using Single Photon Emission Computed Tomography (SPECT) With Technetium-99m-ethyl Cysteinatedimer (Tc-ECD) (NCT01037686) | Sheba Medical Center | 2006-02-01 |
| Genetic Polymorphism and Parkinson's Disease in Taiwanese (NCT01996878) | Changhua Christian Hospital | 2006-02-01 |
| The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations (NCT00286897) | Eisai Limited | 2006-02-01 |
| Deep Brain Stimulation in HUCH Region Between 2006 and 2014 (NCT02652104) | Hospital District of Helsinki and Uusimaa | 2006-01-01 |
| Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease (NCT01683292) | South Glasgow University Hospitals NHS Trust | 2006-01-01 |
| Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease (NCT00292227) | UCB Pharma | 2006-01-01 |
| European Compliance Study in Parkinson's Disease (NCT00466739) | South Glasgow University Hospitals NHS Trust | 2006-01-01 |
| Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites (NCT02772614) | Bial - Portela C S.A. | 2006-01-01 |
| A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease (NCT00250393) | Kyowa Kirin Co., Ltd. | 2005-11-01 |
| Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease (NCT00253084) | Impax Laboratories, LLC | 2005-11-01 |
| A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease (NCT00256204) | Teva Branded Pharmaceutical Products R&D, Inc. | 2005-11-01 |
| Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease (NCT00260793) | Agarwal, Pinky, M.D. | 2005-11-01 |
| Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease (NCT00134251) | Solvay Pharmaceuticals | 2005-10-01 |
| Low Dose Apomorphine and Parkinsonism (NCT00472355) | Oregon Health and Science University | 2005-10-01 |
| Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease (NCT00912808) | Oregon Health and Science University | 2005-10-01 |
| An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001 (NCT00199381) | Kyowa Kirin, Inc. | 2005-10-01 |
| A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations (NCT00165789) | Eisai Inc. | 2005-09-01 |
| Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa (NCT02774564) | Bial - Portela C S.A. | 2005-09-01 |
| Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease (NCT00224263) | Xuanwu Hospital, Beijing | 2005-09-01 |
| Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease (NCT00692328) | Oregon Health and Science University | 2005-08-01 |
| A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa (NCT00134966) | Novartis | 2005-08-01 |
| Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States (NCT00143026) | Novartis | 2005-07-01 |
| Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease (NCT00125138) | Lundbeck LLC | 2005-07-01 |
| Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension) (NCT00642889) | Newron Pharmaceuticals SPA | 2005-06-01 |
| Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease (NCT00252850) | Sangamo Therapeutics | 2005-06-01 |
| A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease (NCT00139880) | UCB Pharma | 2005-06-01 |
| The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease (NCT00163085) | Pfizer | 2005-05-01 |
| Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease (NCT00271141) | Hillel Yaffe Medical Center | 2005-05-01 |
| A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients (NCT00199433) | Kyowa Kirin, Inc. | 2005-05-01 |
| Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson's Disease (NCT00385073) | Austin Health | 2005-04-01 |
| Adherence of Stalevo, Entacapone and Levodopa (NCT00245700) | South Glasgow University Hospitals NHS Trust | 2005-04-01 |
| A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa (NCT00199355) | Kyowa Kirin Co., Ltd. | 2005-04-01 |
| Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide (NCT00202657) | Société Française de Cardiologie | 2005-04-01 |
| Pergolide Treatment and Valvular Heart Disease (NCT00234364) | Århus Amt | 2005-03-01 |
| Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa (NCT00203957) | University of Chicago | 2005-03-01 |
| Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists (NCT00196898) | German Parkinson Study Group (GPS) | 2005-03-01 |
| Parkin Mutations and Their Functional Consequences (NCT00136721) | Institut National de la Santé Et de la Recherche Médicale, France | 2005-02-08 |
| Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease (NCT00153972) | Technische Universität Dresden | 2005-02-01 |
| Treatment of Executive Dysfunction in Parkinson's Disease (NCT00286949) | Johns Hopkins University | 2005-01-06 |
| Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy (NCT00103597) | Royal Brisbane and Women's Hospital | 2005-01-01 |
| A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients (NCT01634243) | Otsuka Pharmaceutical Co., Ltd. | 2005-01-01 |
| Masked Faces in Parkinson Disease: Mechanism and Treatment (NCT00350402) | University of Florida | 2004-12-01 |
| A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease (NCT00242008) | UCB Pharma | 2004-12-01 |
| A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease (NCT00199394) | Kyowa Kirin Co., Ltd. | 2004-11-01 |
| A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease (NCT00243971) | UCB Pharma | 2004-11-01 |
| A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease (NCT00229736) | Genzyme, a Sanofi Company | 2004-11-01 |
| Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations (NCT01634360) | Eisai Inc. | 2004-11-01 |
| Ipratropium Spray for Drooling Saliva in Parkinson's Disease (NCT00296946) | University Health Network, Toronto | 2004-11-01 |
| An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 (NCT00199368) | Kyowa Kirin, Inc. | 2004-10-01 |
| Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia (NCT00105521) | EMD Serono | 2004-09-30 |
| Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia (NCT00105508) | EMD Serono | 2004-09-30 |
| Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease (NCT00296959) | University Health Network, Toronto | 2004-09-01 |
| Development of a Face Valid Executive Functioning Task (NCT00918112) | Washington University School of Medicine | 2004-09-01 |
| Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy (NCT00099268) | Novartis Pharmaceuticals | 2004-09-01 |
| A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa (NCT00199420) | Kyowa Kirin, Inc. | 2004-07-01 |
| Methylphenidate and Parkinson's Disease (NCT00359723) | Oregon Health and Science University | 2004-07-01 |
| Stress-Busting Program for Caregivers of Patients With Neruological Diseases (NCT00122174) | US Department of Veterans Affairs | 2004-07-01 |
| Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) (NCT00104585) | Columbia University | 2004-07-01 |
| A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa (NCT00199407) | Kyowa Kirin, Inc. | 2004-06-01 |
| Galantamine Executive Function in Parkinson's Disease (NCT00211588) | Memorial Hospital of Rhode Island | 2004-06-01 |
| Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease (NCT00203138) | Teva Branded Pharmaceutical Products R&D, Inc. | 2004-06-01 |
| Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies (NCT00142363) | Institut National de la Santé Et de la Recherche Médicale, France | 2004-05-01 |
| A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias (NCT01172379) | Eisai Limited | 2004-05-01 |
| Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients (NCT00179101) | Vanderbilt University | 2004-04-01 |
| Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug (NCT00087542) | ACADIA Pharmaceuticals Inc. | 2004-03-01 |
| An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease (NCT00632736) | GlaxoSmithKline | 2004-02-01 |
| A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions (NCT00673088) | Roxane Laboratories | 2004-02-01 |
| A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions (NCT00674310) | Roxane Laboratories | 2004-02-01 |
| A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease (NCT00139867) | UCB Pharma | 2004-01-01 |
| Expiratory Muscle Training in Patients With Parkinson's Disease (NCT00843739) | University of Florida | 2004-01-01 |
| Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin (NCT00111982) | Amgen | 2003-12-01 |
| Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's (NCT00363727) | GlaxoSmithKline | 2003-12-01 |
| Functional Characterization of Parkin + Patients (NCT00142311) | Institut National de la Santé Et de la Recherche Médicale, France | 2003-11-01 |
| Parkinson's Disease Registry of the Muhammad Ali Parkinson Center (NCT00217321) | Muhammad Ali Parkinson Research Center | 2003-11-01 |
| Electronic Compliance Monitoring in Parkinson's Disease (NCT00361205) | South Glasgow University Hospitals NHS Trust | 2003-11-01 |
| POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease (NCT00234676) | The Parkinson Study Group | 2003-10-01 |
| Intravenous Versus Inhalational Anesthesia in Parkinson's Disease (NCT00615472) | Columbia University | 2003-10-01 |
| Glutathione (GSH) In The Treatment of Parkinson's Disease (NCT01177319) | University of South Florida | 2003-09-01 |
| Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease (NCT00180037) | Technische Universität Dresden | 2003-09-01 |
| Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease (NCT00195143) | Neurologix, Inc. | 2003-08-01 |
| D-serine Adjuvant Treatment for Parkinson's Disease (NCT00215904) | Herzog Hospital | 2003-08-01 |
| Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease (NCT00666653) | Oregon Health and Science University | 2003-07-01 |
| Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes (NCT00792532) | University of California, San Francisco | 2003-07-01 |
| Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease (NCT00095810) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2003-07-01 |